|
|
Vijande, J., Valcarce, A., Carames, T. F., & Garcilazo, H. (2013). Heavy Hadron Spectroscopy: A Quark Model Perspective. Int. J. Mod. Phys. E, 22(5), 1330011–25pp.
Abstract: We present recent results of hadron spectroscopy and hadron hadron interaction from the perspective of constituent quark models. We pay special attention to the role played by higher-order hock space components in the hadron spectra and the connection of this extension with the hadron-hadron interaction. The main goal of our description is to obtain a coherent understanding of the low-energy hadron phenomenology without enforcing any particular model, to constrain its characteristics and learn about the low-energy realization of the theory.
|
|
|
|
Vijande, J., Valcarce, A., Carames, T. F., & Garcilazo, H. (2013). Heavy hadron spectroscopy: A quark model perspective. Nucl. Phys. A, 914, 472–481.
Abstract: We present recent results of hadron spectroscopy and hadron-hadron interaction from the perspective of constituent quark models. We pay special attention to the role played by higher order Fock space components in the hadron spectra and the connection of this extension with the hadron-hadron interaction. The main goal of our description is to obtain a coherent understanding of the low-energy hadron phenomenology without enforcing any particular model, to constrain its characteristics and learn about low-energy realization of the theory.
|
|
|
|
Vijande, J., & Valcarce, A. (2014). Unraveling the pattern of the XYZ mesons. Phys. Lett. B, 736, 325–328.
Abstract: We present a plausible mechanism for the origin of the XYZ mesons in the heavy meson spectra within a standard quark-model picture. We discuss the conditions required for the existence of four-quark bound states or resonances contributing to the heavy meson spectra, being either compact or molecular. We concentrate on charmonium and bottomonium spectra, where several new states, difficult to understand as simple quark-antiquark pairs, have been reported by different experimental collaborations. The pivotal role played by entangled meson-meson thresholds is emphasized.
|
|
|
|
Vijande, J., Tedgren, A. C., Ballester, F., Baltas, D., Papagiannis, P., Rivard, M. J., et al. (2021). Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates. Phys. Imag. Radiat. Oncol., 19, 108–111.
Abstract: Background and purpose: Brachytherapy treatment outcomes depend on the accuracy of the delivered dose distribution, which is proportional to the reference air-kerma rate (RAKR). Current societal recommendations require the medical physicist to compare the measured RAKR values to the manufacturer source calibration certificate. The purpose of this work was to report agreement observed in current clinical practice in the European Union. Materials and methods: A European survey was performed for high- and pulsed-dose-rate (HDR and PDR) highenergy sources (Ir-192 and Co-60), to quantify observed RAKR differences. Medical physicists at eighteen hospitals from eight European countries were contacted, providing 1,032 data points from 2001 to 2020. Results: Over the survey period, 77% of the Ir-192 measurements used a well chamber instead of the older Krieger phantom method. Mean differences with the manufacturer calibration certificate were 0.01% +/- 1.15% for Ir-192 and -0.1% +/- 1.3% for Co-60. Over 95% of RAKR measurements in the clinic were within 3% of the manufacturer calibration certificate. Conclusions: This study showed that the agreement level was generally better than that reflected in prior societal recommendations positing 5%. Future recommendations on high-energy HDR and PDR source calibrations in the clinic may consider tightened agreements levels.
|
|
|
|
Vijande, J., Granero, D., Perez-Calatayud, J., & Ballester, F. (2013). Monte Carlo dosimetric study of the medium dose rate CSM40 source. Appl. Radiat. Isot., 82, 283–288.
Abstract: The Cs-137 medium dose rate (MDR) CSM40 source model (Eckert & Ziegler BEBIG, Germany) is in clinical use but no dosimetric dataset has been published. This study aims to obtain dosimetric data for the CSM40 source for its use in clinical practice as required by the American Association of Physicists in Medicine (AAPM) and the European Society for Radiotherapy and Oncology (ESTRO). Penelope2008 and Geant4 Monte Carlo codes were used to characterize this source dosimetrically. It was located in an unbounded water phantom with composition and mass density as recommended by AAPM and ESTRO. Due to the low photon energies of Cs-137, absorbed dose was approximated by collisional kerma. Additional simulations were performed to obtain the air-kerma strength, sic. Mass-energy absorption coefficients in water and air were consistently derived and used to calculate collisional kerma. Results performed with both radiation transport codes showed agreement typically within 0.05%. Dose rate constant, radial dose function and anisotropy function are provided for the CSM40 and compared with published data for other commercially available Cs-137 sources. An uncertainty analysis has been performed. The data provided by this study can be used as input data and verification in the treatment planning systems. (C) 2013 Elsevier Ltd. All rights reserved.
|
|
